文献速递儿童感染儿童呼吸

巴西儿科重症监护病房脓毒症流行病学研究(SPREAD PED)

The epidemiology of sepsis in paediatric intensive care units in Brazil (the Sepsis PREvalence Assessment Database in Pediatric population, SPREAD PED): an observational study.
PubMed 文献 · Lancet Child Adolesc Health · 2021-10-29

该研究在巴西全国范围开展1天时点患病率调查并随访至出院或死亡,纳入28天至18岁符合严重脓毒症或脓毒性休克标准的患儿。较高的pSOFA评分、疫苗接种状态不明或不完整、医疗保健相关感染及抗生素依从性与死亡风险增加相关。

要点

  • 疫苗接种状态不明或不完整及医疗保健相关感染与死亡风险增加相关。

核心结论

  • 在巴西这一中等收入国家的代表性PICU样本中,严重脓毒症或脓毒性休克的患病率和院内死亡率均较高。
  • 可改变因素如疫苗接种不完整和医疗保健相关感染与较高的院内死亡风险相关。

研究设计与样本

  • 全国性、1天、前瞻性时点患病率研究,采用分层随机抽样选取巴西所有PICU,于2019年3月25日至29日单日纳入患者并随访至出院或死亡(截尾60天)。
  • 纳入标准为年龄28天至18岁、住院期间任何时间符合严重脓毒症或脓毒性休克标准;共144个PICU(1242张床位)参与,研究日1122名患儿入住,其中280名符合标准。
  • 使用Poisson回归模型评估死亡危险因素,并利用患病率生成全国估计。

临床怎么用

  • 在PICU中应关注严重脓毒症或脓毒性休克的高患病率及院内死亡风险,及时识别并评估病情严重度。
  • pSOFA评分可用于风险分层,评分较高者死亡风险增加。
  • 确保疫苗接种状态明确且完整,并预防医疗保健相关感染,可能有助于降低院内死亡风险。
  • 抗生素依从性与死亡风险相关,提示需关注抗生素使用的规范性与及时性。

局限性

  • 研究为1天时点患病率调查,可能受季节性或单日收治情况影响。
  • 部分患者临床数据不完整(252例完整临床数据用于死亡率分析)。
  • 研究仅纳入巴西PICU,外推至其他国家或非PICU环境需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on the prevalence and mortality of paediatric sepsis in resource-poor settings are scarce. We aimed to assess the prevalence and in-hospital mortality of severe sepsis and septic shock treated in paediatric intensive care units (PICUs) in Brazil, and risk factors for mortality. METHODS: We performed a nationwide, 1-day, prospective point prevalence study with follow-up of patients with severe sepsis and septic shock, using a stratified random sample of all PICUs in Brazil. Patients were enrolled at each participating PICU on a single day between March 25 and 29, 2019. All patients occupying a bed at the PICU on the study day (either admitted previously or on that day) were included if they were aged 28 days to 18 years and met the criteria for severe sepsis or septic shock at any time during hospitalisation. Patients were followed up until hospital discharge or death, censored at 60 days. Risk factors for mortality were assessed using a Poisson regression model. We used prevalence to generate national estimates. FINDINGS: Of 241 PICUs invited to participate, 144 PICUs (capacity of 1242 beds) included patients in the study. On the day of the study, 1122 children were admitted to the participating PICUs, of whom 280 met the criteria for severe sepsis or septic shock during hospitalisation, resulting in a prevalence of 25·0% (95% CI 21·6-28·8), with a mortality rate of 19·8% (15·4-25·2; 50 of 252 patients with complete clinical data). Increased risk of mortality was associated with higher Pediatric Sequential Organ Failure Assessment score (relative risk per point increase 1·21, 95% CI 1·14-1·29, p<0·0001), unknown vaccination status (2·57, 1·26-5·24; p=0·011), incomplete vaccination status (2·16, 1·19-3·92; p=0·012), health care-associated infection (2·12, 1·23-3·64, p=0·0073), and compliance with antibiotics (2·38, 1·46-3·86, p=0·0007). The estimated incidence of PICU-treated sepsis was 74·6 cases per 100 000 paediatric population (95% CI 61·5-90·5), which translates to 42 374 cases per year (34 940-51 443) in Brazil, with an estimated mortality of 8305 (6848-10 083). INTERPRETATION: In this representative sample of PICUs in a middle-income country, the prevalences of severe sepsis or septic shock and in-hospital mortality were high. Modifiable factors, such as incomplete vaccination and health care-associated infections, were associated with greater risk of in-hospital mortality. FUNDING: Fundação de Amparo à Pesquisa do Estado de São Paulo and Conselho Nacional de Desenvolvimento Científico e Tecnológico. TRANSLATION: For the Portuguese translation of the abstract see Supplementary Materials section.

来源:Lancet Child Adolesc Health,查看原文。版权归原作者所有。

引用

  1. de Souza DC, Gonçalves Martin J, Soares Lanziotti V, et al. The epidemiology of sepsis in paediatric intensive care units in Brazil (the Sepsis PREvalence Assessment Database in Pediatric population, SPREAD PED): an observational study. Lancet Child Adolesc Health. 2021. PMID: 34756191. doi:10.1016/S2352-4642(21)00286-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。